Nephrol Dial Transplant (2003) 18: 590-597
© 2003 European Renal Association-European Dialysis and Transplant Association
Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients
1 Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden and 2 Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea
Background. The recent ADEMEX study (Paniagua R, Amato D, Vonesh E et al. J Am Soc Nephrol 2002; 13: 1307–1320) indicates that peritoneal small solute clearance is not as critical for the survival of peritoneal dialysis (PD) patients as thought previously. On the other hand, low residual renal function (RRF), inflammation and an increased peritoneal transport rate (PTR) as evaluated by the peritoneal equilibration test (PET) are reported to be associated with increased mortality in PD patients, but the relationships between these factors and their separate and combined impact on the survival of PD patients are not clear. In this retrospective analysis, we evaluated possible relationships between RRF, inflammation and initial PTR in patients starting PD and the impact of these factors on patient survival.
Methods. A total of 117 patients with initial assessments for RRF, serum C-reactive protein (CRP) and PET at a mean period of 0.4±0.2 months (range 0.1–1.0 months) after start of PD were included in this study. Based on RRF (cut-off point, 4 ml/min/1.73 m2), serum CRP (cut-off point, 10 mg/l), and the dialysate to plasma creatinine ratio at 4-h of dwell (mean+1 SD), the patients were divided into different groups: low RRF and high RRF group, high CRP and normal CRP group and high PTR and other PTR group, respectively.
Results. Of 117 patients, 54 patients (46%) were in low RRF (<4 ml/min/1.73 m2) group, 36 patients (31%) were in high serum CRP (
10 mg/l) group and 17 patients (15%) were in high PTR group. Forty-nine patients (42%) had one of these characteristics, 26 patients (22%) had two of these characteristics, two patients (2%) had three, and 40 patients (34%) had none of these characteristics. Patients with low RRF were older and had a higher prevalence of high CRP, lower normalized protein equivalent of total nitrogen appearance (nPNA), lower total Kt/Vurea and lower total creatinine clearance (CCr) whereas patients with high CRP were older and had a higher proportion of men, lower serum albumin, lower nPNA, lower RRF and lower total CCr. Patients with high PTR had lower serum albumin, higher RRF and higher total CCr compared with patients with other PTR. Upon logistic multiple regression analysis, age and RRF were identified as factors affecting inflammation. Overall patient survival was significantly lower in the patients with low RRF, with high CRP, and in patients with more than two of the following: low RRF, high CRP and high PTR. In contrast, in patients with none of the discriminators low RRF, high CRP and high PTR, the 5-year survival was 100%. A high PTR was associated with decreased survival during the initial year on PD, but not thereafter. Patients who died during the follow-up period had a higher prevalence of high CRP and lower serum albumin, lower RRF, lower Kt/Vurea and lower total CCr. Upon Cox proportional hazards multivariate analysis, age and RRF were predictors of mortality.
Conclusions. These results indicate that in patients starting PD, low initial RRF is associated with inflammation, and low RRF and inflammation are both associated with high overall mortality. A high PTR was associated with higher mortality, but only during the initial year on PD, whereas Kt/Vurea did not predict mortality. These results indicate the importance of RRF and inflammation as predictors of mortality in PD patients whereas the predictive power of PTR as such may lose its significance if these two parameters are taken into consideration.
Keywords: inflammation; mortality; peritoneal transport rate; residual renal function
Correspondence and offprint requests to: Bengt Lindholm, MD, PhD, Divisions of Baxter Novum and Renal Medicine, K 56 Huddinge, University Hospital, S-141 86 Huddinge, Sweden. Email: bengt.lindholm{at}klinvet.ki.se
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Y.-M. Wang, C. W.-K. Lam, I. H.-S. Chan, M. Wang, S.-F. Lui, and J. E. Sanderson Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3826 - 3833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Jiang, J. Qian, W. Sun, A. Lin, L. Cao, Q. Wang, Z. Ni, Y. Wan, B. Linholm, J. Axelsson, et al. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2551 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ignace, D. Fouque, W. Arkouche, J.-P. Steghens, and F. Guebre-Egziabher Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1685 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Cueto-Manzano RAPID SOLUTE TRANSPORT IN THE PERITONEUM: PHYSIOLOGIC AND CLINICAL CONSEQUENCES Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S90 - S95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Liu, H.-H. Lin, Y.-F. Yang, Y.-L. Liu, H.-L. Kuo, I-K. Wang, C.-Y. Chou, and C.-C. Huang SUBCLINICAL PERIPHERAL ARTERY DISEASE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS: RISK FACTORS AND OUTCOME Perit. Dial. Int., January 1, 2009; 29(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Wiggins, S. P. McDonald, F. G. Brown, J. B. Rosman, and D. W. Johnson High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3005 - 3012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Y. Lee, H. Y. Choi, H. C. Park, B. J. Seo, J. Y. Do, S. R. Yun, H. Y. Song, Y. H. Kim, Y.-L. Kim, D. J. Kim, et al. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2893 - 2899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Rodrigues, M. Almeida, I. Fonseca, M. Martins, M. J. Carvalho, F. Silva, C. Correia, M. J. Santos, and A. Cabrita Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation Nephrol. Dial. Transplant., March 1, 2006; 21(3): 763 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rumpsfeld, S. P. McDonald, and D. W. Johnson Higher Peritoneal Transport Status Is Associated with Higher Mortality and Technique Failure in the Australian and New Zealand Peritoneal Dialysis Patient Populations J. Am. Soc. Nephrol., January 1, 2006; 17(1): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bammens, P. Evenepoel, K. Verbeke, and Y. Vanrenterghem Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1536 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kalantar-Zadeh, J. D. Kopple, M. H. Humphreys, and G. Block Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1507 - 1519. [Abstract] [Full Text] [PDF]
|
|